• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIOMERIEUX SA VIDAS® FSH 60 TESTS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIOMERIEUX SA VIDAS® FSH 60 TESTS Back to Search Results
Catalog Number 30407
Device Problem High Test Results (2457)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Type  malfunction  
Event Description
Intended use: vidas fsh is an automated quantitative test for use on the vidas family instruments for the determination of human follicle stimulating hormone in human serum or plasma (lithium heparin), using the elfa technique (enzyme linked fluorescent assay).Issue description: on (b)(6) 2021, a customer from (b)(6) reported to biomerieux that they observed out of range high results when testing an external quality control sample with vidas fsh 60 tests ¿ ref.30407, batch 1008522020 , expiry date 14-jan-2022.The external qc sample was seronorm lyo level 2.Seronorm lyo level 2 out of rilibäk range level 2: target 32.30 (range: 27.78 - 36.82) iu/l, 14% deviation allowed.The customer performed the testing with a valid calibration but the results were too high.So the customer performed another calibration using a different batch (batch #1008580750) and level 2 was within the expected range.The customer received a value of 38.14 iu/l (batch# 1008522020) with the first lot and 30.52 (batch #1008580750) with the second lot.There was no patient involved as it was an external quality control sample.A biomérieux internal investigation will be initiated.Note: reference 30407 is not registered in the united states.The u.S.Similar device is product reference 30407-01.
 
Manufacturer Narrative
An internal investigation was performed following notification from a customer from germany that they obtained ¿out of range high¿ results when testing an external quality control sample with vidas fsh 60 tests (ref.(b)(4) lot# 1008522020 , exp.14-jan-2022).Investigation: device history review the device history record review showed no issues occurred during manufacturing for vidas fsh (ref(b)(4) lot 1008522020).Control chart analysis: the complaints laboratory analyzed the control charts for 4 internal samples (targets at 5.78, 14.6, 21,6 and 27.8 iu/l) using 7 batches of vidas® fsh tests, including the customer¿s lots.The analysis showed that all results are within specifications, and the results from the customer¿s lot were consistent with those from the reference lots.Testing: the customer's samples were not submitted for the investigation.As a result, tests were performed on internal samples, retained by biomérieux from the production of the lot.Three samples (targeted at 5.78, 21.63 and 27.75 ui/l) were tested using retained kits of the customer¿s lot and one other lot 1008940110, as a reference.All the results are within specifications.The results with vidas fsh lot 1008522020 are similar to those obtained before the batch release and to the reference lot.Analysis of results of another eqa program (probioqual): the complaints laboratory subscribes to different eqa scheme and tests several quality control samples such as an ordinary user.All the results complied to the supplier expectation and the peer group variability is conform to vidas fsh specification.Conclusion: per the investigation information, no anomaly was highlighted with the control chart analysis, the analysis of quality data, nor the tests performed on internal samples with the retain kit vidas fsh lot 1008522020.The investigation did not manage to identify any obvious root cause.Without the customer sample, no further investigation can be performed.According to the above data , vidas fsh lot 1008522020 is within the expected performance.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VIDAS® FSH 60 TESTS
Type of Device
VIDAS® FSH 60 TESTS
Manufacturer (Section D)
BIOMERIEUX SA
376 chemin de l orme
marcy l etoile 69280
FR  69280
Manufacturer (Section G)
BIOMERIEUX SA
376 chemin de l orme
marcy l etoile 69280
FR   69280
Manufacturer Contact
candace martin
595 anglum road
hazelwood, MO 63042
MDR Report Key12706920
MDR Text Key284807219
Report Number8020790-2021-00199
Device Sequence Number1
Product Code CGJ
Combination Product (y/n)N
Reporter Country CodeGM
PMA/PMN Number
K921746
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,User Facility
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 12/17/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/27/2021
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date01/14/2022
Device Catalogue Number30407
Device Lot Number1008522020
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received11/18/2021
Was Device Evaluated by Manufacturer? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage A
Patient Sequence Number1
-
-